Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management Fig 1. Summary of germline and somatic genomic testing for metastatic prostate cancer recommendations. ARPI, ...
In all patients, results of a platelet factor 4 (PF4)–induced platelet-activation (PIPA) assay were strongly positive, and serum from all the patients tested strongly positive against PF4 alone in a ...
News-Medical.Net on MSN
How somatic mutations shape disease and reveal new drug targets
By Tarun Sai Lomte Scientists reveal how evolution within our own tissues can drive disease, protect cells, and uncover hidden therapeutic targets for future precision medicine. Somatic genomics ...
Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia Strategies to ensure that ...
Cancer is driven mainly by genomic instability, manifesting through a spectrum of somatic mutations that range from single nucleotide substitutions to large-scale chromosomal rearrangements, which ...
Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...
In a recent online publication in SCIENCE CHINA Life Sciences, researchers from the laboratory of Leng-Siew Yeap at the Shanghai Institute of Immunology, Shanghai Jiao Tong University School of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results